ISTDP: Both the individual therapy and the group therapy is based on ISTDP (Intensive Short-Term Dynamic Psychotherapy), an affect-focused psychodynamic therapy method. The therapy focus on the relationship between feelings, anxiety and dysfunctional emotion regulation (i.e. defenses). The purpose is to increase the capacity of anxiety regulation in the patient and to help the patient identify the dysfunctional patterns developed to avoid internal stress and then gradually approach previously warded of feelings. The individual therapy consists of 25 weekly sessions. The group treatment consists of 18 weekly sessions and is structured in three phases. Phase one: Psychoeducation about anxiety and exercises in anxiety regulation. Phase two: patients takes turn to observe their own anxiety and defenses together with a therapist. Phase three: Every session two patients will work with a chosen problem and identify defenses, anxiety and feelings together with a therapist in front of the group.
Study summary
The primary objective of this study is to evaluate the feasibility and acceptability of a 25-week combined group and individual therapy program using Intensive Short-Term Dynamic Psychotherapy (ISTDP) for patients diagnosed with personality disorders. The secondary objective is to investigate preliminary effects of the treatment in terms of reducing symtoms of depression, anxiety and emotion regulation difficulties.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
Personality disorder diagnosis (Clinical assessment using STIP-5) Speaks Swedish fluently
Exclusion Criteria:
Autism or intellectual disability Borderline, antisocial or narcissistic personality disorder diagnosis Need for interpreter Urgent social misery Psychotic disorder High suicidality
Primary outcome measure(s)
Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews — Immediately after treatment completion Patients experience of, and satisfaction with, the treatment assessed through qualitative interviews
Depression symtoms — Baseline, weekly throughout treatment, immediately after treatment completion and 6-month follow-up Depression symtoms will be measured with Patient Health Questionnaire (PHQ-9; (Kroenke et al., 2001)
Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8) — Immediately after treatment completion (25 weeks) Participants satisfaction with treatment assessed with the Client Satisfaction Questionnaire (CSQ-8)
Adverse events related to the treatment — From start of treatment up to. 6 month follow up. Adverse events related to the treatment
Number of individual sessions attended during the treatment — Throughout the treatment period, up to 25 weeks Number of individual sessions attended during the treatment
Number of group sessions attended during the treatment — Throughout the treatment period, up to 25 weeks Number of group sessions attended during the treatment
Number of dropouts — Throughout the treatment period, up to 25 weeks Number of dropouts
Total number of sessions attended during the treatment — Throughout the treatment period, up to 25 weeks Total number of sessions attended during the treatment
Trial sites (1)
Facility
City
Region
Status
Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
